January 2003
5986.
Chang HH, Shyu HF, Wang YM, Sun DS, Shyu RH, Tang SS, Huang YS.
Facilitation of cell adhesion by immobilized dengue viral nonstructural protein
1 (NS1): arginine-glycine-aspartic acid structural mimicry within the dengue
viral NS1 antigen. J Infect Dis 2002
Sep 15;186(6):743-51
Dengue virus infection causes life-threatening hemorrhagic fever.
Increasing evidence implies that dengue viral nonstructural protein 1 (NS1)
exhibits a tendency to elicit potentially hazardous autoantibodies, which show a
wide spectrum of specificity against extracellular matrix and platelet antigens.
How NS1 elicits autoantibodies remains unclear. To address the hypothesis that
NS1 and matrix proteins may have structural and functional similarity,
cell-matrix and cell-NS1 interactions were evaluated using a cell-adhesion
assay. The present study showed that dengue NS1 immobilized on coverslips
resulted in more cell adhesion than did the control proteins. This cell adhesion
was inhibited by peptides containing arginine-glycine-aspartic acid (RGD), a
motif important for integrin-mediated cell adhesion. In addition, anti-NS1
antibodies blocked RGD-mediated cell adhesion. Although there is no RGD motif in
the NS1 protein sequence, these data indicate that RGD structural mimicry exists
within the NS1 antigen.
5987. Drosten C, Gottig S, Schilling S, Asper M,
Panning M, Schmitz H, Gunther S. Rapid detection and quantification of RNA of
Ebola and Marburg viruses, Lassa virus, Crimean-Congo hemorrhagic fever virus,
Rift Valley fever virus, dengue virus, and yellow fever virus by real-time
reverse transcription-PCR. J Clin Microbiol
2002 Jul;40(7):2323-30
Viral hemorrhagic fevers (VHFs) are acute infections with high case
fatality rates. Important VHF agents are Ebola and Marburg viruses (MBGV/EBOV),
Lassa virus (LASV), Crimean-Congo hemorrhagic fever virus (CCHFV), Rift Valley
fever virus (RVFV), dengue virus (DENV), and yellow fever virus (YFV). VHFs are
clinically difficult to diagnose and to distinguish; a rapid and reliable
laboratory diagnosis is required in suspected cases. We have established six
one-step, real-time reverse transcription-PCR assays for these pathogens based
on the Superscript reverse transcriptase-Platinum Taq polymerase enzyme mixture.
Novel primers and/or 5'-nuclease detection probes were designed for RVFV, DENV,
YFV, and CCHFV by using the latest DNA database entries. PCR products were
detected in real time on a LightCycler instrument by using 5'-nuclease
technology (RVFV, DENV, and YFV) or SybrGreen dye intercalation (MBGV/EBOV, LASV,
and CCHFV). The inhibitory effect of SybrGreen on reverse transcription was
overcome by initial immobilization of the dye in the reaction capillaries.
Universal cycling conditions for SybrGreen and 5'-nuclease probe detection were
established. Thus, up to three assays could be performed in parallel,
facilitating rapid testing for several pathogens. All assays were
horoughly optimized and validated in terms of analytical sensitivity by
using in vitro-transcribed RNA. The >or=95% detection limits as determined by
probit regression analysis ranged from 1,545 to 2,835 viral genome
equivalents/ml of serum (8.6 to 16 RNA copies per assay). The suitability of the
assays was exemplified by detection and quantification of viral RNA in serum
samples of VHF patients.
5987.
Endy TP, Nisalak A, Chunsuttiwat S, Libraty DH, Green S, Rothman AL,
Vaughn DW, Ennis FA. Spatial and temporal circulation of dengue virus serotypes:
a prospective study of primary school children in Kamphaeng Phet, Thailand. Am J
Epidemiol 2002 Jul 1;156(1):52-9
Dengue virus occurs as four distinct serotypes, each of which causes
epidemics throughout the tropical and subtropical regions of the world. Few
studies have examined co-circulation of multiple dengue virus serotypes in a
well-defined cohort population over time and their capacity to produce severe
dengue disease. In this paper, the authors report the details and findings of
the first 3 years (1998-2000) of an ongoing prospective study of dengue virus
transmission and disease severity in a cohort of children in northern Thailand.
A total of 108 dengue virus isolates were obtained from 167 acute dengue virus
infections; 23% were DEN-1, 35% were DEN-2, 41% were DEN-3, and 1% were DEN-4.
Despite the proximity of the schools, there was marked spatial and temporal
clustering of transmission of each dengue serotype. Serotype-specific antibody
levels prior to the dengue transmission season were not predictive of the
incidence of dengue virus infections or the predominant serotype transmitted at
individual schools. All dengue serotypes produced severe dengue illness,
although DEN-3 produced more severe symptoms than the other dengue serotypes.
The authors' findings emphasize the complexity of dengue serotype-specific virus
transmission and severe dengue disease and have important implications for
dengue control and vaccine development.
5988.
Garcia-Rivera EJ, Rigau-Perez JG.
Encephalitis and dengue. Lancet 2002
Jul 20;360(9328):261 No abstract.
5989.
Jacobs
M, Levin M. An improved endothelial barrier model to investigate dengue
haemorrhagic fever. J Virol Methods 2002
Jul;104(2):173-85
A cell culture model suitable for studies of dengue haemorrhagic fever
was developed, based on culture of primary human umbilical vein endothelial
cells (HUVECs) on a permeable membrane. By electron microscopy, cultured HUVECs
at day 11 resembled morphologically microvascular endothelium. Endothelial
barrier function was assessed by measuring transendothelial flux of albumin.
Instead of using a labelled tracer molecule, an enzyme-linked immunosorbent
assay (ELISA) was developed to measure concentrations of native human albumin.
The permeability characteristics of the HUVEC monolayer were found to be
improved significantly (approximately 1 log reduction in permeability
coefficient for albumin) by culturing HUVECs in human serum rather than fetal
calf serum. Permeability coefficients for albumin in the range 1-4 x 10(-7) cm/s
were achieved, which is an improvement on previous in vitro models of the
endothelial barrier. Comparison of transendothelial flux of albumin and urea
provided evidence of molecular sieving by the HUVEC monolayer. Moreover, tumour
necrosis factor-alpha induced a dose-dependent, reversible increase in
permeability of the HUVEC monolayer. This endothelial barrier model thus has
many important characteristics that resembled human microvascular endothelium
and is an improvement on the previous model proposed for studies of dengue
haemorrhagic fever.
5990.
King
CA, Anderson R, Marshall JS. Dengue virus selectively induces human mast cell
chemokine production. J Virol 2002
Aug;76(16):8408-19
Severe dengue virus infections usually occur in individuals who have
preexisting anti-dengue virus antibodies. Mast cells are known to play an
important role in host defense against several pathogens, but their role in
viral infection has not yet been elucidated. The effects of dengue virus
infection on the production of chemokines by human mast cells were examined.
Elevated levels of secreted RANTES, MIP-1alpha, and MIP-1beta, but not IL-8 or
ENA-78, were observed following infection of KU812 or HMC-1 human mast cell-basophil
lines. In some cases a >200-fold increase in RANTES production was observed.
Cord blood-derived cultured human mast cells treated with dengue virus in the
presence of subneutralizing concentrations of dengue virus-specific antibody
also demonstrated significantly (P < 0.05) increased RANTES production, under
conditions which did not induce significant degranulation. Chemokine responses
were not observed when mast cells were treated with UV-inactivated dengue virus
in the presence or absence of human dengue virus-specific antibody. Neither
antibody-enhanced dengue virus infection of the highly permissive U937 monocytic
cell line nor adenovirus infection of mast cells induced a RANTES, MIP-1alpha,
or MIP-1beta response, demonstrating a selective mast cell response to dengue
virus. These results suggest a role for mast cells in the initiation of
chemokine-dependent host responses to dengue virus infection.
5991.
Rahman M, Rahman K, Siddque AK, Shoma
S, Kamal AH, Ali KS, Nisaluk A, Breiman RF. First outbreak of dengue hemorrhagic
fever, Bangladesh. Emerg Infect Dis 2002
Jul;8(7):738-40
During the first countrywide outbreak
of dengue hemorrhagic fever in Bangladesh, we conducted surveillance for dengue
at a hospital in Dhaka. Of 176 patients, primarily adults, found positive for
dengue, 60.2% had dengue fever, 39.2% dengue hemorrhagic fever, and 0.6% dengue
shock syndrome. The Dengue virus 3 serotype was detected in eight patients.
5992.
Rele MC, Rasal A, Deshpande SD,
Koppikar GV, Lahiri KR. Indian J med Microbiol. 2001; 19(4): 206-7.
No abstract.
5993.
Van Gorp EC, Setiati TE, Mairuhu AT,
Suharti C, Cate Ht H, Dolmans WM, Van Der Meer JW, Hack CE, Brandjes DP.
Impaired fibrinolysis in the pathogenesis of dengue hemorrhagic fever. J Med
Virol 2002 Aug;67(4):549-54
The mechanisms contributing to bleeding complications in dengue
hemorrhagic fever were studied by investigating the pattern of activation of the
coagulation and fibrinolytic systems in 50 children with severe dengue
hemorrhagic fever. Thirteen patients (26%) died, and activation of coagulation
was most pronounced in the deceased group. Fibrinolysis was also activated, but
this activation was relatively weak compared with that of coagulation as a
result of persistently high plasminogen activator inhibitor levels. Plasminogen
activator inhibitor also prevented a switch from the procoagulant to the
profibrinolytic state in lethal dengue hemorrhagic fever, which was further
enhanced by an acquired protein C deficiency. The present study is the first to
demonstrate such a mechanism in a viral infection. This imbalance between
coagulation and fibrinolysis may be used as a prognostic marker, but it may also
be a target for future therapeutic intervention. Copyright 2002 Wiley-Liss, Inc.
5994.
Wills BA, Oragui EE, Stephens AC,
Daramola OA, Dung NM, Loan HT, Chau NV, Chambers M, Stepniewska K, Farrar JJ,
Levin M. Coagulation abnormalities in dengue hemorrhagic Fever: serial
investigations in 167 Vietnamese children with Dengue shock syndrome. Clin
Infect Dis 2002 Aug 1;35(3):277-85
The
pathophysiological basis of hemorrhage in dengue infections remains poorly
understood, despite the increasing global importance of these infections. A
large prospective study of 167 Vietnamese children with dengue shock syndrome
documented only minor prolongations of prothrombin and partial thromboplastin
times but moderate to severe depression of plasma fibrinogen concentrations. A
detailed study of 48 children revealed low plasma concentrations of the
anticoagulant proteins C, S, and antithrombin III, which decreased with
increasing severity of shock, probably because of capillary leakage. Concurrent
increases in the levels of thrombomodulin, tissue factor, and plasminogen
activator inhibitor type 1 (PAI-1) indicated increased production of these
proteins. Thrombomodulin levels suggestive of endothelial activation correlated
with increasing shock severity, whereas PAI-1 levels correlated with bleeding
severity. Dengue virus can directly activate plasminogen in vitro. Rather than
causing true disseminated intravascular coagulation, dengue infection may
activate fibrinolysis primarily, degrading fibrinogen directly and prompting
secondary activation of procoagulant homeostatic mechanisms.
Pathogenesis:
5996.
Blaney
JE Jr, Johnson DH, Manipon GG, Firestone CY, Hanson CT, Murphy BR, Whitehead SS.
Genetic basis of attenuation of dengue virus type 4 small plaque mutants with
restricted replication in suckling mice and in SCID mice transplanted with human
liver cells. Virology. 2002 Aug 15;300(1):125-39.
Mutations that restrict replication of
dengue virus have been sought for the generation of recombinant live-attenuated
dengue virus vaccines. Dengue virus type 4 (DEN4) was previously grown in Vero
cells in the presence of 5-fluorouracil, and the characterization of 1248
mutagenized, Vero cell passaged clones identified 20 temperature-sensitive (ts)
mutant viruses that were attenuated (att) in suckling mouse brain (J. E. Blaney,
Jr., D. H. Johnson, C. Y. Firestone, C. T. Hanson, B. R. Murphy, and S. S.
Whitehead, 2001, J. Virol. 75(20), 9731-9740). The present investigation has
extended these studies by identifying an additional 22 DEN4 mutant viruses which
have a small plaque size (sp) phenotype in Vero cells and/or the liver cell
line, HuH-7. Five mutant viruses have a sp phenotype in both Vero and HuH-7
cells, three of which are also ts. Seventeen mutant viruses have a sp phenotype
in only HuH-7 cells, 13 of which are also ts. Each of the sp viruses was growth
restricted in the suckling mouse brain, exhibiting a wide range of reduction in
replication (9- to 100,000-fold). Complete nucleotide sequence was determined
for the 22 DEN4 sp mutant viruses, and nucleotide substitutions were found in
the 3'-untranslated region (UTR) as well as in all coding regions except NS4A.
Identical mutations have been identified in multiple virus clones, suggesting
that they may be involved in the adaptation of DEN4 virus to efficient growth in
Vero cells. Six of the 22 sp 5-FU mutant viruses lacked coding mutations in the
structural genes, and 17 recombinant DEN4 viruses were generated which
separately encoded each of the mutations observed in these six sp viruses.
Analysis of the recombinant DEN4 viruses defined the genetic basis of the sp, ts,
and att phenotypes observed in the six sp viruses. Mutations in NS1, NS3, and
the 3'-UTR were found to confer a greater than 100-fold, 10,000-fold, and
1000-fold reduction in replication of rDEN4 virus in SCID mice transplanted with
HuH-7 cells, respectively, which serves as a novel small animal model for DEN4
infection.
5997.
Caplen NJ, Zheng Z, Falgout B, Morgan
RA. Inhibition of viral gene expression and replication in mosquito cells by
dsRNA-triggered RNA interference. Mol Ther. 2002 Aug;6(2):243-51.
Mosquitoes transmit numerous viral pathogens to humans including dengue
virus which affects approximately 50 million individuals per year. Inhibition of
viral gene expression within an insect host could be used to block virus
replication and subsequent transmission of the pathogen to humans. A naturally
occurring gene silencing mechanism triggered by double-stranded RNA (dsRNA), RNA
interference (RNAi), has recently been described in a number of species
including Drosophila. To ascertain if dsRNA-triggered RNAi is present in
mosquito cells, we used Aedes albopictus C6/36 cells, and to investigate the
feasibility of blocking viral gene expression and replication, we used two
mosquito-borne viruses, Semliki Forest virus (SFV) and the serotype 1 dengue
virus (DEN1). We demonstrate that dsRNA can specifically inhibit transgene
expression in C6/36 cells from both plasmid and SFV replicons and can
significantly modify the kinetics of DEN1 RNA and virus replication. The
inhibition mediated by dsRNA was sequence-specific and either equal or superior
to that induced by antisense single-stranded RNA (ssRNA). This study
demonstrates dsRNA-triggered inhibition of gene expression and virus replication
in mosquito cells and suggests that this mechanism could be used to block
pathogen replication within an insect host and, thus, block disease
transmission.
5998.
Hales S, de Wet N, Maindonald J,
Woodward A. Potential effect of population and climate changes on global
distribution of dengue fever: an empirical model. Lancet. 2002 Sep
14;360(9336):830-4.
BACKGROUND: Existing theoretical models of the potential effects of
climate change on vector-borne diseases do not account for social factors such
as population increase, or interactions between climate variables. Our aim was
to investigate the potential effects of global climate change on human health,
and in particular, on the transmission of vector-borne diseases. METHODS: We
modelled the reported global distribution of dengue fever on the basis of vapour
pressure, which is a measure of humidity. We assessed changes in the
geographical limits of dengue fever transmission, and in the number of people at
risk of dengue by incorporating future climate change and human population
projections into our model. FINDINGS: We showed that the current geographical
limits of dengue fever transmission can be modelled with 89% accuracy on the
basis of long-term average vapour pressure. In 1990, almost 30% of the world
population, 1.5 billion people, lived in regions where the estimated risk of
dengue transmission was greater than 50%. With population and climate change
projections for 2085, we estimate that about 5-6 billion people (50-60% of the
projected global population) would be at risk of dengue transmission, compared
with 3.5 billion people, or 35% of the population, if climate change did not
happen. INTERPRETATION: We conclude that climate change is likely to increase
the area of land with a climate suitable for dengue fever transmission, and that
if no other contributing factors were to change, a large proportion of the human
population would then be put at risk.
5999.
Kochel TJ, Watts DM, Halstead SB, Hayes
CG, Espinoza A, Felices V, Caceda R, Bautista CT, Montoya Y, Douglas S, Russell
KL. Effect of dengue-1 antibodies on American dengue-2 viral infection and
dengue haemorrhagic fever. Lancet. 2002 Jul 27;360(9329):310-2.
In Iquitos, Peru, no cases of dengue
haemorrhagic fever have been recorded in individuals infected with dengue-1
virus followed by American genotype dengue-2 (American dengue-2) virus. We
assayed serum samples collected in Iquitos that tested positive for antibodies
of monotype dengue-1 and monotype dengue-2 using a plaque reduction
neutralisation test to determine their ability to neutralise the infectivity of
two dengue-1 viruses, two American dengue-2 viruses, and two Asian dengue-2
viruses. Sera positive for the dengue-1 antibody neutralised dengue-1 viruses
and American dengue-2 viruses much more effectively than Asian dengue-2 viruses.
Neutralisation of American dengue-2 virus by sera positive for dengue-1
antibodies may account for the absence of dengue haemorrhagic fever in
individuals infected with dengue-1 in 1990-91 followed by American dengue-2
virus in 1995 in Iquitos, Peru.
6000.
Lin CF, Lei HY, Shiau AL, Liu HS, Yeh
TM, Chen SH, Liu CC, Chiu SC, Lin YS. Endothelial cell apoptosis induced by
antibodies against dengue virus nonstructural protein 1 via production of nitric
oxide. J Immunol. 2002 Jul 15;169(2):657-64.
The onset of vascular leakage and
hemorrhagic diathesis is one of the life-threatening complications occurring in
dengue patients, yet the pathogenic mechanisms are not well understood. In this
study, we demonstrated that Abs against dengue virus nonstructural protein 1
(NS1) generated in mice cross-reacted with human endothelial cells and mouse
vessel endothelium. After binding, mouse anti-NS1 Abs induced endothelial cell
apoptosis in a caspase-dependent manner. Inducible NO synthase expression could
be observed; it showed a time- and dose-dependent correlation with NO
production. Endothelial cell apoptosis, characterized by exposure of
phosphatidylserine on the cell surface and nuclear DNA fragmentation, was
blocked by treatment with the NO synthase inhibitor N(omega)-nitro-L-arginine
methyl ester. Further studies demonstrated that the expression of Bcl-2 and
Bcl-x(L) decreased in both mRNA and protein levels, whereas p53 and Bax
increased after anti-NS1 treatment. Cytochrome c release was also observed. All
of these effects could be inhibited by N(omega)-nitro-L-arginine methyl ester.
Taken together, anti-NS1 Abs act as autoantibodies that cross-react with
noninfected endothelial cells and trigger the intracellular signaling leading to
the production of NO and to apoptosis. Endothelial cell damage may cause
vascular leakage that contributes to the pathogenesis of dengue disease.
6001.
Perelygin
AA, Scherbik SV, Zhulin IB, Stockman BM, Li Y, Brinton MA. Positional cloning of
the murine flavivirus resistance gene. Proc Natl Acad Sci U S A. 2002 Jul
9;99(14):9322-7.
Inbred mouse strains exhibit significant differences in their
susceptibility to viruses in the genus Flavivirus, which includes human
pathogens such as yellow fever, Dengue, and West Nile virus. A single gene,
designated Flv, confers this differential susceptibility and was mapped
previously to a region of mouse chromosome 5. A positional cloning strategy was
used to identify 22 genes from the Flv gene interval including 10 members of the
2'-5'-oligoadenylate synthetase gene family. One 2'-5'-oligoadenylate synthetase
gene, Oas1b, was identified as Flv by correlation between genotype and phenotype
in nine mouse strains. Susceptible mouse strains produce a protein lacking 30%
of the C-terminal sequence as compared with the resistant counterpart because of
the presence of a premature stop codon. The Oas1b gene differs from all the
other murine Oas genes by a unique four-amino acid deletion in the P-loop
located within the conserved RNA binding domain. Expression of the resistant
allele of Oas1b in susceptible embryo fibroblasts resulted in partial inhibition
of the replication of a flavivirus but not of an alpha togavirus.
Therapy:
6002.
Johnson O. Venezuela launches new campaign against dengue fever. BMJ
2002 Sep 7;325(7363):512 No
abstract.
6003.
Teixeira
Mda G, Barreto ML, Costa Mda C, Ferreira LD, Vasconcelos PF, Cairncross S.
Dynamics of dengue virus circulation: a silent epidemic in a complex urban area.
Trop Med Int Health 2002
Sep;7(9):757-62
Serotypes
of dengue DEN-1 and DEN-2 have been reported in much of Brazil over the last 15
years, and DEN-3 serotype was only recently detected. This - prospective study
was conducted in Salvador, a large city in north-east Brazil, where two
epidemics were previously recorded (DEN-1 and DEN-2). We obtained the
seroprevalence and 1-year incidence of dengue infections in the population of 30
sampling areas of Salvador and analysed the relationship between intensity of
viral circulation, standard of living and vector density. High seroprevalence
(68.7%) and annual incidence (70.6%) of infection for one or both circulating
serotypes (DEN-1 and DEN-2) were found. High rates of transmission were observed
in all studied areas, from the highest to the lowest socio-economic status. The
mean PI (Premise Index) for Aedes aegypti was 7.4% (range 0.27-25.6%). Even in
the areas with the lowest PI (</=3%) the observed seroincidence was 54.6%.
These findings highlighted the existence of a silent epidemic during a period
perceived by the Health Services as of low endemicity, indicating the strength
and speed of dengue transmission in the city of Salvador.
April 2003
6634.
Arora
MM; Mishra KB; Nair V; Bhardwaj JR; Bhalwar R; Somani BL.
Diagnosing disseminated intravascular coagulation in acute infection :
can we do without FDP & D-DIMER. Medical Journal Armed Forces India. 2002
Jan; 58(1): 13-7.
ABSTRACT: Alterations in coagulation profile viz. platelet count, prothrombin time (PT), partial thromboplastin time with kaolin (PTTK), thrombin time (TT) and fibrinogen were studied in 96 patients (73 males and 23 females) of acute infections. Fibrin/fibrinogen degradation products (FDP) level 25miug fibrinogen equivalent unit (FEU)/ml along-with D-dimer 1.0miug FEU/ml was considered criteria for diagnosis of disseminated intravascular coagulation (DIC). Normal values were established using plasma from 12 healthy voluntary blood donors. Out of these 96 patients, 15 had infection with Gram positive bacteria, 23 with Gram negative bacteria and 38 with Dengue. In 20 patients, nature of infection was not defined. Mean platelet count per cubic millimeter was 2.14 lac in Gram positive infection and 1.74 lac in Gram negative infection (p=0.07). There was no significant difference in other coagulation parameters in Gram positive and Gram negative infection. Platelet counts were low in 71 percent of Dengue patients but there was no significant alteration in PT, PTTK and TT. None of the Dengue patients had hypofibrinogenemia or DIC though hyperfibrinogenemia was present in 21 percent of Dengue patients. 20 patients had features of septicemia (Gram +ve 7, Gram-ve 8, undefined 5); 10 had concomitant DIC. DIC was present in additional 4 patients of acute infection without septicemia. PTTK was raised in 60 percent of the septicemia patients. 20 out of 82 non- DIC acute infection patients had subnormal PTTK. Commonest alteration in 14 DIC patients was raised PTTK with a sensitivity of 78.6 percent and specificity of 81.7 percent. Low fibrinogen levels though specific for DIC, were present in only 21.4 percent of the DIC patients. Combinations of PTTK 38 sec with PT15 sec or platelet count 1.5 lac/mm cube were good screening tests for DIC and detected 11 and 10 patients out of 14 with three and two false positives respectively.
6635.
Dutta P , Khan S A , Khan A M , Sharma C K , Doloi P K , Mahant J .
Soloid waste pollution and breeding Potential of dengue vector in urban and
industrial environment of Assam J
envir biol ,Lucknow 1999,20(4),343-5. (ISA
014219, Vol 38 No14 ,16 July 2002)
6636.
Libraty DH, Young PR, Pickering D, Endy TP, Kalayanarooj S, Green S,
Vaughn DW, Nisalak A, Ennis FA, Rothman AL. High circulating levels of the
dengue virus nonstructural protein NS1 early in dengue illness correlate with
the development of dengue hemorrhagic fever.
J Infect Dis 2002 Oct
15;186(8):1165-8
Infection
with any 1 of 4 dengue viruses produces a spectrum of clinical illness ranging
from a mild undifferentiated febrile illness to dengue fever (DF) to dengue
hemorrhagic fever (DHF), a potentially life-threatening disease. The morbidity
and mortality of DHF can be reduced by early hospitalization and careful
supportive care. To determine its usefulness as a predictor of DHF, plasma
levels of the secreted dengue virus nonstructural protein NS1 (sNS1) were
measured daily in 32 children with dengue-2 virus infections participating in a
prospective, hospital-based study. Free sNS1 levels in plasma correlated with
viremia levels and were higher in patients with DHF than in those with DF. An
elevated free sNS1 level (> or =600 ng/mL) within 72 h of illness onset
identified patients at risk for developing DHF.
Pathogenesis:
6637.
Lin YL, Lei HY, Lin YS, Yeh TM, Chen SH, Liu HS. Heparin inhibits
dengue-2 virus infection of five human liver cell lines. Antiviral Res
2002 Oct;56(1):93-6
Liver
is suggested to be the major target of dengue virus infection and plays an
important role in the immunopathogenesis of dengue hemorrhagic fever.
Previously, we reported that five human liver cell lines (HuH-7, HA22T, Hep3B,
PLC, and Chang liver) with various degrees of differentiation and tumorigenicity
showed different susceptibility for dengue virus infection. Here, we demonstrate
that heparin, an analogue of heparan sulfate (HS), can compete with HS on cell
membrane for virus binding and subsequently inhibits the replication of dengue-2
and Japanese encephalitis viruses in hepatoma and BHK-21 cells, respectively. It
indicates that the binding of these viruses with HS is an important process for
their invasion. Moreover, the inhibitory effect of heparin correlates with the
infectivity of the virus in the cells. All together, our results suggest that HS
is an important host component for dengue and Japanese encephalitis virus
replication, which can be effectively blocked by heparin.
6638.
Lin YW, Wang KJ, Lei HY, Lin YS,
Yeh TM, Liu HS, Liu CC, Chen SH. Virus replication and cytokine production in
dengue virus-infected human B lymphocytes. J Virol
2002 Dec;76(23):12242-9
Dengue
virus (DV) replication, antibody-enhanced viral infection, and cytokine
responses of human primary B lymphocytes (cells) were characterized and compared
with those of monocytes. The presence of a replication template (negative-strand
RNA intermediate), viral antigens including core and nonstructural proteins, and
increasing amounts of virus with time postinfection indicated that DV actively
replicated in B cells. Virus infection also induced B cells to produce
interleukin-6 and tumor necrosis factor alpha, which have been previously
implicated in virus pathogenesis. In addition, a heterologous antibody was able
to enhance both virus and cytokine production in B cells. Furthermore, the
levels of virus replication, antibody-enhanced virus replication, and cytokine
responses observed in B cells were not statistically different from those in
monocytes. These results suggest that B cells may play an important role in DV
pathogenesis.
Vaccines:
6639.
Halstead SB, Deen J. The future of dengue vaccines. Lancet 2002 Oct 19;360(9341):1243-5. No abstract.
Therapy:
6640.
Van Benthem BH, Khantikul N, Panart K, Kessels PJ, Somboon P, Oskam L.
Knowledge and use of prevention measures related to denguen northern Thailand.
Trop Med Int Health 2002
Nov;7(11):993-1000
OBJECTIVE:
To determine the frequency and determinants of knowledge of dengue infection in
three sites in northern Thailand, and to compare prevention measures of people
with and without knowledge of dengue. METHODS: In May 2001 we conducted an
epidemiological survey among 1650 persons living in three areas in northern
Thailand. Knowledge of dengue and the use of prevention measures were measured
by means of a structured questionnaire. Differences in knowledge of dengue and
the use of prevention measures between risk groups were calculated by chi-square
test. Logistic regression was used to identify determinants of knowledge.
RESULTS: Of the 1650 persons, 67% had knowledge of dengue. Fever (81%) and rash
(77%) were the most frequently mentioned symptoms. Persons with knowledge of
dengue reported a significantly higher use of prevention measures than persons
without knowledge of dengue. In multivariate analyses, knowledge of dengue
significantly differed by age, sex, occupation and site (P < 0.05). Younger
people knew more about dengue than older persons: adjusted odds ratio (aOR) of
6.75 [95% confidence interval (CI): 4.32-10.6] for the 15-29 age group compared
with people aged 60 and older. In comparison with farmers (reference group),
knowledge of dengue was significantly higher among students (aOR: 10.6, 95% CI:
4.27-26.4), but lower among housewives or unemployed persons (aOR: 0.44, 95% CI:
0.31-0.64). CONCLUSION: The overall knowledge of dengue was high, but
housewives, unemployed and old persons had relatively little knowledge of
dengue. Therefore, these groups may need special attention in future dengue
education programmes. Persons with knowledge of the disease more frequently
reported the use of preventive measures, indicating the value of education
programmes as a tool in dengue prevention.
July 2003
7057.
Espina LM, Valero NJ, Hernandez JM, Mosquera JA. Increased apoptosis and
expression of tumor necrosis factor-alpha caused by infection of cultured human
monocytes with dengue virus. Am J Trop Med Hyg
2003 Jan;68(1):48-53
Dengue (DEN) virus is responsible for
one of the most significant viral diseases in tropical countries. Monocytes/macrophages
(Mo/Mphi) are the major target cells for DEN virus. To determine the effects of
the interaction between DEN virus and Mo/Mphi, human monocyte cultures were
infected with DEN virus type 2. Apoptosis and production of tumor necrosis
factor-alpha (TNF-alpha) and nitric oxide were measured in control and infected
cultures. Virus was taken up by phagocytosis, but no membrane-coated pits at the
virus attachment sites were observed. Increased number of apoptotic cells and
increased production of TNF-a were observed in infected monocyte cultures. No
increase in production of nitric oxide was observed. These results may be
related to early primary viral infection, in which virus could induce apoptosis
in monocytes, but monocytes may contribute to host defense mechanisms against
virus by viral phagocytosis, phagocytosis of infected apoptotic cells, and the
release of proinflammatory cytokines.
7058.
Lin CF, Lei HY, Shiau AL, Liu CC, Liu HS, Yeh TM, Chen SH, Lin YS.
Antibodies from dengue patient sera cross-react with endothelial cells and
induce damage. J Med Virol 2003
Jan;69(1):82-90
Dengue virus infection causes a wide
range of diseases from the mild febrile illness dengue fever to the
life-threatening dengue hemorrhagic fever (DHF) and dengue shock syndrome (DSS).
Vascular leakage and hemorrhagic syndrome are the clinical features associated
with dengue infection, yet the mechanisms remain unclear. In this study, the
cross-reactivity of dengue patient sera with endothelial cells was demonstrated.
There were higher percentages of endothelial cells reactive with dengue
hemorrhagic fever/dengue shock syndrome patient sera than those with dengue
fever patient sera. The percentages of endothelial cells reactive with patient
serum IgM were higher than those with IgG. Further studies showed that the
endothelial cell binding activity was inhibited by pretreatment with dengue
virus nonstructural protein 1 (NS1). The antibodies against NS1 produced after
dengue virus infection may, at least in part, account for the cross-reactivity
of patient sera with endothelial cells. Furthermore, dengue patient sera induced
endothelial cell apoptosis via a caspase-dependent pathway that was also
inhibited by NS1 pretreatment. In addition to apoptosis, patient sera caused
cell lysis in the presence of complement, and DHF/DSS patient sera showed higher
percentages of cytotoxicity than dengue fever patient sera. Thus, the generation
of cross-reactive autoantibodies against endothelial cells would lead to their
dysfunction, which may play a role in the pathogenesis of dengue virus
infection. Copyright 2003 Wiley-Liss, Inc.
7059.
Mairuhu AT, Mac Gillavry MR, Setiati TE, Soemantri A, ten Cate H,
Brandjes DP, van Gorp EC. Is clinical outcome of dengue-virus infections
influenced by coagulation and fibrinolysis? A critical review of the evidence.
Lancet Infect Dis 2003
Jan;3(1):33-41
Despite efforts to elucidate the
pathogenesis of dengue fever, the progression into severe disease remains poorly
understood. In-vitro findings suggest that coagulopathy and disturbances in
fibrinolysis have a pivotal role in the pathophysiology. If disturbances in
these processes are predictive of clinical outcome in this disease, there could
be important consequences for both diagnosis and treatment. We have critically
reviewed publications on this topic to assess whether there is an association
between activation of coagulation and fibrinolysis and clinical outcome of
dengue-virus infections. In general, the selected studies showed activation of
both the coagulation and fibrinolytic systems in this infection. The activation
was more pronounced in severe infections and in cases with a poor clinical
outcome. However, the findings were not consistent, and owing to a lack of
detailed information on characteristics of patients, disease, and study design,
we could not ascertain whether inconsistencies were caused by differences in
these characteristics, selection bias, or confounding factors. We conclude that
an association between activation of coagulation and fibrinolysis and clinical
outcome of dengue-virus infections is conceivable but has been inadequately
assessed and that methodologically sound studies, complemented with complete and
reliable reporting, are needed to show whether there is a true association.
7060.
Yocupicio-Monroy RM, Medina F, Reyes-del Valle J, del Angel RM. Cellular
proteins from human monocytes bind to dengue 4 virus minus-strand 3'
untranslated region RNA. J Virol 2003
Mar;77(5):3067-76
The synthesis of plus and minus RNA
strands of several RNA viruses requires as a first step the interaction of some
viral regulatory sequences with cellular and viral proteins. The dengue 4 virus
genome, a single-stranded, positive-polarity
RNA, is flanked by two untranslated regions (UTR) located in the 5' and
3' ends. The 3'UTR in the minus-strand RNA [3'UTR (-)] has been thought to
function as a promoter for the synthesis of plus-strand RNA. To study the
initial interaction between this 3'UTR and cellular and viral proteins, mobility
shift assays were performed, and four ribonucleoprotein complexes (I through IV)
were formed when uninfected and infected U937 cells (human monocyte cell line)
interacted with the 3'UTR (-) of dengue 4 virus. Cross-linking assays with RNAs
containing the complete 3'UTR (-) (nucleotides [nt] 101 to 1) or a partial
sequence from nt 101 to 45 and nt 44 to 1 resulted in specific binding of some
cellular proteins. Supermobility shift and immunoprecipitation assays
demonstrated that the La protein forms part of these complexes. To determine the
region in the 3' UTR that interacted with the La protein, two deletion mutants
were generated. The mutant (del-96), with a deletion of nt 96 to 101, was unable
to interact with the La protein, suggesting that La interacted with the 5'
portion of the 3'UTR (-). Complex I, which was the main ribonucleoprotein
complex formed with the 3'UTR (-) and which had the fastest electrophoretic
migration, contained proteins such as calreticulin and protein disulfide
isomerase, which constitute important components of the endoplasmic reticulum.
Pathogenesis:
7061.
Lin CF, Lei HY, Shiau AL, Liu CC, Liu HS, Yeh TM, Chen SH, Lin YS. Antibodies from dengue patient sera cross-react with
endothelial cells and induce damage. J Med Virol. 2003 Jan;69(1):82-90.
Dengue virus infection causes a wide
range of diseases from the mild febrile illness dengue fever to the
life-threatening dengue hemorrhagic fever (DHF) and dengue shock syndrome (DSS).
Vascular leakage and hemorrhagic syndrome are the clinical features associated
with dengue infection, yet the mechanisms remain unclear. In this study, the
cross-reactivity of dengue patient sera with endothelial cells was demonstrated.
There were higher percentages of endothelial cells reactive with dengue
hemorrhagic fever/dengue shock syndrome patient sera than those with dengue
fever patient sera. The percentages of endothelial cells reactive with patient
serum IgM were higher than those with IgG. Further studies showed that the
endothelial cell binding activity was inhibited by pretreatment with dengue
virus nonstructural protein 1 (NS1). The antibodies against NS1 produced after
dengue virus infection may, at least in part, account for the cross-reactivity
of patient sera with endothelial cells. Furthermore, dengue patient sera induced
endothelial cell apoptosis via a caspase-dependent pathway that was also
inhibited by NS1 pretreatment. In addition to apoptosis, patient sera caused
cell lysis in the presence of complement, and DHF/DSS patient sera showed higher
percentages of cytotoxicity than dengue fever patient sera. Thus, the generation
of cross-reactive autoantibodies against endothelial cells would lead to their
dysfunction, which may play a role in the pathogenesis of dengue virus
infection. Copyright 2003 Wiley-Liss, Inc.
7062.
Oliveira SA, Siqueira MM, Camacho LA, Castro-Silva R, Bruno BF, Cohen BJ.
Use of RT-PCR on oral fluid samples to assist the identification of
measles cases during an outbreak. Epidemiol Infect. 2003 Feb;130(1):101-6.
This study investigated the occurrence
of mild modified measles cases during an outbreak in Niteroi, RJ, Brazil by
using RT-PCR on oral fluid samples. From August to December 1997 a total of 76
patients with rash were seen at the study sites. Confirmed diagnosis by serology
was achieved in 47 cases: measles (39.5%), rubella (13.2%), HHV-6 (3.9%), human
parvovirus B19 (3.9%), dengue fever (3%). For 19 of the 29 patients without a
conclusive diagnosis paired serum and saliva samples were available for further
tests. In four of them, measles virus RNA was dete cted by RT-PCR in saliva
samples in the absence of specific IgM in serum samples. Vaccination histories
obtained from three of the RT-PCR positive cases showed that individuals
previously immunized can still be infected and contribute to the circulation of
measles virus. This study demonstrated the usefulness of RT-PCR on non-invasive
clinical samples for the investigation of measles cases.
7063.
Suksanpaisan L, Smith DR. Analysis
of saturation binding and saturation infection for dengue serotypes 1 and 2 in
liver cells. Intervirology. 2003;46(1):50-5.
OBJECTIVE: The liver has been
increasingly recognized as a significant target organ in the pathogenesis of
dengue virus infection. However, only two contradictory studies have examined
the binding of the dengue virus to liver cells. This study therefore sought to
investigate the binding of the dengue virus to HepG2 cells. METHODS:
Radiolabeled dengue virus serotypes 1 and 2 were prepared through viral
propagation in Vero cells. Increasing amounts of virus were then incubated with
HepG2 cells to determine the ability of the virus to achieve saturation of
binding on HepG2 cells. RESULTS: Results indicated that it was not possible to
reach saturation of binding under experimentally achievable conditions. We then
sought to determine whether it was possible to reach a state of saturation of
infection, by using increasingly high titers of virus on a constant number of
cells. Dengue serotype 1 showed no evidence of saturation of infection, even at
titers of 5,000 viruses per cell. In contrast, dengue serotype 2 became
saturated at levels of approximately 3,000 viruses per cell. CONCLUSIONS: These
results are consistent with proposals that dengue virus binding to cells is
mediated initially through a low-affinity interaction with an abundant molecule
on the surface of the cell and secondly through interaction with a less commonly
expressed molecule, which is required for viral internalization. Copyright 2003
S. Karger AG, Basel
7064.
Yocupicio-Monroy RM, Medina F, Reyes-del Valle J, del Angel RM.
Cellular proteins from human monocytes bind to dengue 4 virus
minus-strand 3' untranslated region RNA. J Virol. 2003 Mar;77(5):3067-76.
The synthesis of plus and minus RNA
strands of several RNA viruses requires as a first step the interaction of some
viral regulatory sequences with cellular and viral proteins. The dengue 4 virus
genome, a single-stranded, positive-polarity RNA, is flanked by two untranslated
regions (UTR) located in the 5' and 3' ends. The 3'UTR in the minus-strand RNA
[3'UTR (-)] has been thought to function as a promoter for the synthesis of
plus-strand RNA. To study the initial interaction between this 3'UTR and
cellular and viral proteins, mobility shift assays were performed, and four
ribonucleoprotein complexes (I through IV) were formed when uninfected and
infected U937 cells (human monocyte cell line) interacted with the 3'UTR (-) of
dengue 4 virus. Cross-linking assays with RNAs containing the complete 3'UTR (-)
(nucleotides [nt] 101 to 1) or a partial sequence from nt 101 to 45 and nt 44 to
1 resulted in specific binding of some cellular proteins. Supermobility shift
and immunoprecipitation assays demonstrated that the La protein forms part of
these complexes. To determine the region in the 3' UTR that interacted with the
La protein, two deletion mutants were generated. The mutant (del-96), with a
deletion of nt 96 to 101, was unable to interact with the La protein, suggesting
that La interacted with the 5' portion of the 3'UTR (-). Complex I, which was
the main ribonucleoprotein complex formed with the 3'UTR (-) and which had the
fastest electrophoretic migration, contained proteins such as calreticulin and
protein disulfide isomerase, which constitute important components of the
endoplasmic reticulum.
October 2003
7859.
Imbert-Laurenceau E, Crepinior J,
Crance JM, Jouan A, Migonney V. Polystyrene derivatives substituted with
arginine interact with Babanki (Togaviridae) and Kedougou (Flaviviridae)
viruses. J Med Virol. 2003 Apr;69(4):503-9.
Outbreaks
of new or old diseases appear primarily in tropical zones such as Africa, south
and central America, or Asia. Among these diseases, those induced by Arboviruses
(the best known of which are being yellow fever, dengue, Ebola, and Sindbis) are
under intensive observation by the World Health Organization. Rapid isolation
and identification of the viral species is the first step in the diagnosis,
study, and control of epidemics. One major problem with the isolation of viruses
is capturing sufficient numbers of viral particles to test. The work presented
in this report addresses this question. We have tested the interaction between
Babanki (Togaviridae), Kedougou (Flaviviridae) viruses, and a range of insoluble
polystyrene derivatives substituted with arginine groups. Insoluble
functionalized copolymers were found to develop specific interactions with
viruses through chemical groups present on their surfaces. The adsorption of
viruses varied according to the percentage of arginine substituted onto the
polymer, with a maximum value for both viruses of about 20% of grafting rate. It
was also found that the Kedougou virus displayed the highest affinity for this
polymer. Copyright 2003 Wiley-Liss, Inc.
7860.
Koraka P, Murgue B, Deparis X, Setiati
TE, Suharti C, van Gorp EC, Hack CE, Osterhaus AD, Groen J. Elevated levels of
total and dengue virus-specific immunoglobulin E in patients with varying
disease severity. J Med Virol. 2003 May;70(1):91-8.
The
kinetics of total and dengue virus-specific immunoglobulin E (IgE) were studied
in serial serum samples obtained from 168 patients, 41 of whom suffered from
primary dengue virus infection and 127 suffered from secondary dengue virus
infection. Seventy-one patients were classified as dengue fever, 30 as dengue
hemorrhagic fever, and 67 as dengue shock syndrome. A control group included
single serum samples from patients with a herpes virus infection (n = 14),
non-dengue febrile patients (n = 10), and healthy blood donors (n = 10).
Patients with dengue virus infection had higher levels of total and dengue
virus-specific IgE than non-dengue patients (P < 0.05). Patients with
secondary dengue virus infections had not significantly increased levels of both
total and dengue virus-specific IgE in the acute phase of disease compared to
patients with primary dengue virus infections. Dengue virus-specific IgE was
significantly higher in dengue hemorrhagic fever and/or dengue shock syndrome
patients compared to dengue fever and non-dengue patients (P < 0.05). In
conclusion, this study showed elevated total and dengue virus-specific IgE serum
antibody levels in the acute stage of disease. Therefore, measurement of both
total and dengue virus-specific IgE serum antibodies can be used as an
additional prognostic marker in the development of severe complications in
dengue virus infections. In addition, the presence and increase of dengue
virus-specific IgE serum antibodies in patients with dengue virus infections is
suggestive of the pathogenetic role that IgE may play in the hemostatic
disorders observed in dengue hemorrhagic fever and dengue shock syndrome.
7861.Shu PY, Chang SF, Kuo YC, Yueh YY,
Chien LJ, Sue CL, Lin TH, Huang JH. Development of group- and serotype-specific
one-step SYBR green I-based real-time reverse transcription-PCR assay for dengue
virus. J Clin Microbiol. 2003 Jun;41(6):2408-16.
A
quantitative one-step SYBR Green I-based reverse transcription (RT)-PCR system
was developed for the detection and differentiation of four different dengue
virus serotypes in acute-phase serum samples. A set of group- and serotype-specific
primer pairs was designed against conserved sequences in the core region and
evaluated for clinical diagnosis. A linear relationship was obtained between the
amount of input RNA and cycle threshold (Ct) value over a range of 10 to 10(7)
PFU per ml of cell culture-derived dengue viruses. The detection limit of the
group-specific primer pair was between 4.1 and 43.5 PFU/ml for four dengue
serotypes. The detection limit of each of the serotype-specific primer pairs was
calculated to be 10 PFU/ml for dengue virus serotype 1 (DEN-1), 4.6 PFU/ml for
DEN-2, 4.1 PFU/ml for DEN-3, and 5 PFU/ml for DEN-4. Comparisons between the
one-step SYBR Green-based RT-PCR assay and the conventional cell culture method
in the clinical diagnosis of dengue virus infection from acute-phase serum
samples of confirmed dengue patients were performed. The results showed that 83
and 67% of 193 acute-phase serum samples tested were positive by the one-step
SYBR Green-based RT-PCR method and cell culture method, respectively. Further
analysis showed that the one-step SYBR Green-based RT-PCR method could detect
twice as many acute-phase serum samples with positive dengue-specific
immunoglobulin M (IgM) and/or IgG antibodies than cell culture method. Our
results demonstrate the potential clinical application of the one-step SYBR
Green I-based RT-PCR assay for the detection and differentiation of dengue virus
RNA.
7862.
Vazquez S, Valdes O, Pupo M, Delgado I,
Alvarez M, Pelegrino JL, Guzman MG. MAC-ELISA and ELISA inhibition methods for
detection of antibodies after yellow fever vaccination. J Virol Methods. 2003
Jun 30;110(2):179-84.
The
IgM antibody capture ELISA (MAC-ELISA) and ELISA inhibition methods for the
detection of antibodies against dengue virus were modified to detect antibodies
against yellow fever virus. Tests were carried out in 21 persons vaccinated with
17D and compared with the Plaque reduction neutralizing test. Of 17 naïve
subjects vaccinated, 16 (94%) seroconverted using the MAC-ELISA test and 14
(82%) seroconverted (or >/=fourfold titer increase) in the ELISA inhibition
method. Cross-reactivity was evaluated by both tests and resulted in a high
specificity to IgM antibodies against yellow fever, when all the samples from
vaccinated individuals were negative by MAC-ELISA using dengue antigen. However,
10.7% of the positive dengue sera from the Santiago de Cuba epidemic
cross-reacted by MAC-ELISA using yellow fever antigen. ELISA inhibition method
showed high cross-reactivity when the 21 sera pairs were worked with yellow
fever and dengue antigens. The MAC-ELISA and ELISA inhibition methods have
become indispensable tools in our laboratory in order to maintain a surveillance
system for dengue and dengue hemorrhagic fever. They are relatively rapid,
simple, and they do not require sophisticated equipment. Both MAC-ELISA and
ELISA
inhibition methods for yellow fever could be useful for diagnosis, surveillance
and yellow fever vaccine evaluation.
Pathogenesis
7863.
Blaney JE Jr, Manipon GG, Murphy BR,
Whitehead SS. Temperature sensitive
mutations in the genes encoding the NS1, NS2A, NS3, and NS5 nonstructural
proteins of dengue virus type 4 restrict replication in the brains of mice. Arch
Virol. 2003 May;148(5):999-1006.
7864.
Cologna R, Rico-Hesse R.
American genotype structures decrease dengue virus output from human
monocytes and dendritic cells. J Virol. 2003 Apr;77(7):3929-38.
7865.
Jones CT, Ma L, Burgner JW, Groesch TD,
Post CB, Kuhn RJ. Flavivirus
capsid is a dimeric alpha-helical protein. J Virol. 2003 Jun;77(12):7143-9.
7866.
Koraka P, Murgue B, Deparis X, Setiati
TE, Suharti C, van Gorp EC, Hack CE, Osterhaus AD, Groen J.
Elevated levels of total and dengue virus-specific immunoglobulin E in
patients with varying disease severity. J Med Virol. 2003 May;70(1):91-8.
7867.
Tassaneetrithep B, Burgess TH,
Granelli-Piperno A, Trumpfheller C, Finke J, Sun W, Eller MA, Pattanapanyasat K,
Sarasombath S, Birx DL, Steinman RM, Schlesinger S, Marovich MA. DC-SIGN (CD209) mediates dengue virus infection of human
dendritic cells. J Exp Med. 2003 Apr 7;197(7):823-9.
7868.
Wei HY, Jiang LF, Xue YH, Fang DY, Guo
HY. Secreted expression of dengue
virus type 2 full-length envelope glycoprotein in Pichia pastoris. J Virol
Methods. 2003 Apr;109(1):17-23.
Vaccines:
7869.
Konishi E, Terazawa A, Imoto J. Simultaneous immunization with DNA and
protein vaccines against Japanese encephalitis or dengue synergistically
increases their own abilities to induce neutralizing antibody in mice. Vaccine.
2003 May 16;21(17-18):1826-32.
Gene-based
and protein-based vaccines are two distinct types of vaccines. In this report,
we examined if combined use of DNA and protein vaccines would increase their own
abilities to induce neutralizing antibody in murine models for Japanese
encephalitis (JE) or dengue type 2 (DEN2). DNA vaccines for JE (pcJEME) or DEN2
(pcD2ME) were inoculated intramuscularly, and protein vaccines consisting of
subviral extracellular particles (EPs) containing JE (JEEP) or DEN2 (D2EP) virus
antigens were inoculated subcutaneously with Freund's adjuvant. Two
immunizations of ICR mice with pcJEME and/or JEEP in the prime-boost protocol
indicated that levels of neutralizing antibody induced by the pcJEME prime-JEEP
boost vaccination were two to eight-fold higher than those induced by pcJEME
alone, but were equivalent to those induced by JEEP alone and slightly higher
than those induced by the JEEP prime-pcJEME boost regimen. On the other hand,
simultaneous immunization of ICR mice with pcJEME and JEEP provided
synergistically higher neutralizing antibody titers than those provided by
immunization with either immunogen. Immunization with graded doses of pcJEME and
JEEP confirmed the synergism. The synergistic increase in neutralizing antibody
titer by simultaneous immunization with DNA and protein vaccines was also shown
by immunization with pcD2ME and D2EP in ICR and ddY mice. Both IgG1 and IgG2a
antibodies were induced by combined immunization with pcJEME and JEEP.
7870.
Puttikhunt C, Kasinrerk W, Srisa-ad S, Duangchinda T, Silakate W, Moonsom
S, Sittisombut N, Malasit P. Production of anti-dengue NS1 monoclonal antibodies
by DNA immunization. J Virol Methods. 2003 Apr;109(1):55-61.
Monoclonal
antibodies against dengue NS1 protein were generated following immunization of
mice with plasmid DNA encoding the transmembrane form of NS1 from dengue
serotype 2 virus. A mammalian expression vector, pDisplay, was engineered to
direct cell surface expression of dengue NS1 and tested for transient expression
in COS cells. Two mice were immunized intramuscularly with six doses of 100
microg of plasmid at 2-week intervals; one mouse received a booster of live
virus prior to the last plasmid injection. Both mice showed antibody responses
against dengue antigens in dot enzyme immunoassay. Following fusion, hybridomas
were screened with dot enzyme immunoassay against all four dengue serotypes.
Specificity to the NS1 protein was confirmed by western blot analysis. Among
five anti-dengue NS1 monoclonal antibodies generated, two clones were serotype 2
specific, two clones reacted with all four serotypes and the last also reacted
with Japanese encephalitis virus. Reactivity against native or denatured forms
of NS1 revealed three clones with reactivity to linear epitopes and two clones
recognizing conformational epitopes. Such diverse specificity of anti-dengue NS1
monoclonal antibodies indicates that DNA immunization, especially with the
combination of virus boosting, is an efficient way of producing monoclonal
antibodies against viral protein. This has opened up a possibility of producing
monoclonal antibodies to rare viral proteins that are difficult to isolate or
purify.
Therapy:
7871.
Ostronoff M, Ostronoff F, Florencio R, Florencio M, Domingues MC, Calixto
R, Sucupira A, Souto Maior AP, Matias C, Matias K, Tagliari C, Soussain C.
Serious thrombocytopenia due to dengue hemorrhagic fever treated with high
dosages of immunoglobulin. Clin Infect Dis. 2003 Jun 15;36(12):1623-4.
No abstract
7872.
Puttikhunt C, Kasinrerk W, Srisa-ad S, Duangchinda T, Silakate W, Moonsom
S, Sittisombut N, Malasit P. Production of anti-dengue NS1 monoclonal antibodies
by DNA immunization. J Virol Methods. 2003 Apr;109(1):55-61.
Monoclonal
antibodies against dengue NS1 protein were generated following immunization of
mice with plasmid DNA encoding the transmembrane form of NS1 from dengue
serotype 2 virus. A mammalian expression vector, pDisplay, was engineered to
direct cell surface expression of dengue NS1 and tested for transient expression
in COS cells. Two mice were immunized intramuscularly with six doses of 100
microg of plasmid at 2-week intervals; one mouse received a booster of live
virus prior to the last plasmid injection. Both mice showed antibody responses
against dengue antigens in dot enzyme immunoassay. Following fusion, hybridomas
were screened with dot enzyme immunoassay against all four dengue serotypes.
Specificity to the NS1 protein was confirmed by western blot analysis. Among
five anti-dengue NS1 monoclonal antibodies generated, two clones were serotype 2
specific, two clones reacted with all four serotypes and the last also reacted
with Japanese encephalitis virus. Reactivity against native or denatured forms
of NS1 revealed three clones with reactivity to linear epitopes and two clones
recognizing conformational epitopes. Such diverse specificity of anti-dengue NS1
monoclonal antibodies indicates that DNA immunization, especially with the
combination of virus boosting, is an efficient way of producing monoclonal
antibodies against viral protein. This has opened up a possibility of producing
monoclonal antibodies to rare viral proteins that are difficult to isolate or
purify.